Philip Morris International: money over morality?
Yet, controversial marketing strategies targeting young people and ongoing forceful rebranding of cigarettes in low-income countries indicate an unprecedented degree of corporate hypocrisy, and serious concerns about the safety of the smoke-free alternatives are mounting. According to the Global Bur...
Gespeichert in:
Veröffentlicht in: | The Lancet (British edition) 2019-08, Vol.394 (10200), p.709-709 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Yet, controversial marketing strategies targeting young people and ongoing forceful rebranding of cigarettes in low-income countries indicate an unprecedented degree of corporate hypocrisy, and serious concerns about the safety of the smoke-free alternatives are mounting. According to the Global Burden of Disease Study, in 2015 alone, smoking caused more than one in ten deaths worldwide and killed more than 6 million people, resulting in a global loss of nearly 150 million disability-adjusted life-years. With sales of more than 740 billion cigarettes each year, 90% of revenue stemming from cigarette sales, rising sales and expanding market share in developing countries, aggressive lobbying, and relentless efforts to curtail controls and restrictions on smoking put in place to protect the public, never has there been so duplicitous or nonsensical a corporate manoeuvre as PMI's campaign in promoting a smoke-free future while whitewashing its role in subverting global tobacco control efforts. |
---|---|
ISSN: | 0140-6736 1474-547X |
DOI: | 10.1016/S0140-6736(19)31998-1 |